Pharmacy benefit forecast for a new interferon Beta-1a for the treatment of multiple sclerosis: development of a first-line decision tool for pharmacy-budget planning using administrative claims data.

Journal of managed care pharmacy : JMCP

Volumn 9, Issue 2, 2003, Pages 168-174

  Meyer, Christina M ^a   Phipps, Robert ^a   Cooper, Deborah ^a   Wright, Alan ^a  

^a AdvancePCS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; BETA1A INTERFERON; IMMUNOLOGICAL ADJUVANT;

AGE; AGED; ARTICLE; BUDGET; COST BENEFIT ANALYSIS; DECISION MAKING; ECONOMICS; FEMALE; HEALTH INSURANCE; HUMAN; MALE; METHODOLOGY; MIDDLE AGED; MULTIPLE SCLEROSIS; PHARMACY; PUBLICATION; SUBCUTANEOUS DRUG ADMINISTRATION;

ADJUVANTS, IMMUNOLOGIC; AGE FACTORS; AGED; BUDGETS; COST-BENEFIT ANALYSIS; DECISION MAKING; FEMALE; FORMULARIES; HUMANS; INJECTIONS, SUBCUTANEOUS; INSURANCE, PHARMACEUTICAL SERVICES; INTERFERON-BETA; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; PHARMACEUTICAL SERVICES;

EID: 0642339213     PISSN: 10834087     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)